{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:34:02Z","timestamp":1791920042882,"version":"4.3.4"},"reference-count":152,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01ES023470"],"award-info":[{"award-number":["R01ES023470"]}]},{"name":"NIH","award":["R01HL123358"],"award-info":[{"award-number":["R01HL123358"]}]},{"name":"NIH","award":["R21ES022745"],"award-info":[{"award-number":["R21ES022745"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bbagrm.2016.02.015","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T12:15:09Z","timestamp":1456575309000},"page":"1112-1120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Novel functions of PXR in cardiometabolic disease"],"prefix":"10.1016","volume":"1859","author":[{"given":"Changcheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagrm.2016.02.015_bb0005","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1101\/gad.12.20.3195","article-title":"SXR, a novel steroid and xenobiotic-sensing nuclear receptor","volume":"12","author":"Blumberg","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)80900-9","article-title":"An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway","volume":"92","author":"Kliewer","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0015","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1073\/pnas.95.21.12208","article-title":"Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction","volume":"95","author":"Bertilsson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/er.2001-0038","article-title":"The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism","volume":"23","author":"Kliewer","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0025","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.07001","article-title":"The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism","volume":"7","author":"Zhou","year":"2009","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0030","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1101\/gad.12.20.3149","article-title":"Orphan nuclear receptors\u2013new ligands and new possibilities","volume":"12","author":"Blumberg","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome P-450 3A4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0040","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/MCB.14.3.1544","article-title":"A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements","volume":"14","author":"Baes","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0045","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/26996","article-title":"Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta","volume":"395","author":"Forman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0050","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/35038112","article-title":"The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism","volume":"407","author":"Wei","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0055","doi-asserted-by":"crossref","first-page":"37739","DOI":"10.1074\/jbc.R100033200","article-title":"Orphan nuclear receptors: the exotics of xenobiotics","volume":"276","author":"Xie","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/mend.14.1.0409","article-title":"The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution","volume":"14","author":"Jones","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0009-2797(01)00163-6","article-title":"Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics","volume":"134","author":"LeCluyse","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0070","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1289\/ehp.1104426","article-title":"Bisphenol a and its analogues activate human pregnane x receptor","volume":"120","author":"Sui","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1210\/mend.14.3.0424","article-title":"Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate pregnane X receptor-mediated transcription","volume":"14","author":"Masuyama","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0080","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/eje.0.1450513","article-title":"Bisphenol-A, an environmental estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic receptor-mediated transcription","volume":"145","author":"Takeshita","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0085","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/dmd.104.000299","article-title":"Tocotrienols activate the steroid and xenobiotic receptor, SXR, and selectively regulate expression of its target genes","volume":"32","author":"Zhou","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.110.170225","article-title":"Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation","volume":"335","author":"Cheng","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0095","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1124\/mol.65.5.1159","article-title":"Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression","volume":"65","author":"Hartley","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(11)60814-3","article-title":"Health and economic burden of the projected obesity trends in the USA and the UK","volume":"378","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0110","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0115","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.300.11.1353","article-title":"Bisphenol a and risk of metabolic disorders","volume":"300","author":"Vom Saal","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-physiol-012110-142200","article-title":"Endocrine disruptors: from endocrine to metabolic disruption","volume":"73","author":"Casals-Casas","year":"2011","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.envres.2011.05.014","article-title":"Urinary bisphenol A and obesity: NHANES 2003-2006","volume":"111","author":"Carwile","year":"2011","journal-title":"Environ. Res."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an Endocrine Society scientific statement","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0135","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.reprotox.2006.12.010","article-title":"Developmental exposure to endocrine disruptors and the obesity epidemic","volume":"23","author":"Newbold","year":"2007","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0140","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/me.2005-0367","article-title":"Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates","volume":"20","author":"Grun","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11154-007-9049-x","article-title":"Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis","volume":"8","author":"Grun","year":"2007","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2011.08.007","article-title":"Endocrine disrupting chemicals and disease susceptibility","author":"Schug","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"Suppl. 4","key":"10.1016\/j.bbagrm.2016.02.015_bb0155","first-page":"715","article-title":"Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop","volume":"104","author":"Kavlock","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0160","series-title":"Our Stolen Future","author":"Colborn","year":"1996"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050193","article-title":"The toxic origins of disease","volume":"5","author":"Gross","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1289\/ehp.6560","article-title":"Highly chlorinated PCBs inhibit the human xenobiotic response mediated by the steroid and xenobiotic receptor (SXR)","volume":"112","author":"Tabb","year":"2004","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/toxsci\/kfq394","article-title":"Selective phthalate activation of naturally occurring human constitutive androstane receptor splice variants and the pregnane X receptor","volume":"120","author":"DeKeyser","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0180","first-page":"23","article-title":"Rifampicin-induced early phase hyperglycemia in humans","volume":"125","author":"Takasu","year":"1982","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM196907102810208","article-title":"Hyperglycemia with relative hypoinsulinemia in diphenylhydantoin toxicity","volume":"281","author":"Peters","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1634\/theoncologist.12-1-99","article-title":"Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: a Hoosier Oncology Group trial, HEM01-21","volume":"12","author":"Suvannasankha","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0195","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2337\/db12-1039","article-title":"PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice","volume":"62","author":"He","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0200","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/diab.34.9.911","article-title":"Enzyme inducers improve insulin sensitivity in non-insulin-dependent diabetic subjects","volume":"34","author":"Lahtela","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0205","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1128\/MCB.24.18.7931-7940.2004","article-title":"Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes","volume":"24","author":"Kodama","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0210","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/432958a","article-title":"Diabetes: outfoxing insulin resistance?","volume":"432","author":"Montminy","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0215","doi-asserted-by":"crossref","first-page":"45139","DOI":"10.1074\/jbc.M405423200","article-title":"Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. functional implications in hepatic cholesterol and glucose metabolism","volume":"279","author":"Bhalla","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BJ20070481","article-title":"Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene","volume":"407","author":"Kodama","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0225","doi-asserted-by":"crossref","first-page":"9768","DOI":"10.1074\/jbc.M610072200","article-title":"Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver","volume":"282","author":"Nakamura","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0230","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature03047","article-title":"Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes","volume":"432","author":"Wolfrum","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0235","article-title":"Activation of pregnane X receptor by pregnenolone 16 alpha-carbonitrile prevents high-fat diet-induced obesity in AKR\/J mice","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0240","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1074\/jbc.M511116200","article-title":"A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway","volume":"281","author":"Zhou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbalip.2008.12.008","article-title":"PXR agonism decreases plasma HDL levels in ApoE3-Leiden.CETP mice","volume":"1791","author":"de Haan","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0250","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/toxsci\/kfs211","article-title":"Chronic exposure to rifaximin causes hepatic steatosis in pregnane x receptor-humanized mice","volume":"129","author":"Cheng","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1021\/mp800131d","article-title":"Activation of the nuclear receptor PXR decreases plasma LDL-cholesterol levels and induces hepatic steatosis in LDL receptor knockout mice","volume":"6","author":"Hoekstra","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0260","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/hep.22907","article-title":"A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte","volume":"49","author":"Moreau","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0265","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1074\/jbc.M113.494575","article-title":"Role of pregnane X receptor in obesity and glucose homeostasis in male mice","volume":"289","author":"Spruiell","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0270","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bcp.2014.03.019","article-title":"Role of human pregnane X receptor in high fat diet-induced obesity in pre-menopausal female mice","volume":"89","author":"Spruiell","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0275","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0280","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","article-title":"Executive summary: heart disease and stroke statistics\u20132010 update: a report from the American Heart Association","volume":"121","author":"Lloyd- Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0290","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. The road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0295","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0041-3879(74)90050-6","article-title":"Hyperlipidaemia as a complication of rifampicin treatment","volume":"55","author":"Khogali","year":"1974","journal-title":"Tubercle"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0300","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0305","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1468-1293.2005.00328.x","article-title":"The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations","volume":"6","author":"Shafran","year":"2005","journal-title":"HIV Med."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0310","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/WNL.45.6.1155","article-title":"Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy","volume":"45","author":"Eiris","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0315","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1194\/jlr.M800608-JLR200","article-title":"Activation of PXR induces hypercholesterolemia in wild-type and accelerates atherosclerosis in apoE deficient mice","volume":"50","author":"Zhou","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0320","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5414\/CPP42307","article-title":"Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men","volume":"42","author":"Lutjohann","year":"2004","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0325","doi-asserted-by":"crossref","first-page":"33309","DOI":"10.1074\/jbc.C100375200","article-title":"Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR","volume":"276","author":"Dussault","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0330","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0335","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/157016206775197664","article-title":"Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection","volume":"4","author":"Barbaro","year":"2006","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0340","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2009.10.035","article-title":"The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population","volume":"210","author":"Lu","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0345","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0350","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1073\/pnas.051014398","article-title":"An essential role for nuclear receptors SXR\/PXR in detoxification of cholestatic bile acids","volume":"98","author":"Xie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0355","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1073\/pnas.0336235100","article-title":"Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance","volume":"100","author":"Dussault","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0360","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1073\/pnas.0237082100","article-title":"Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor","volume":"100","author":"Goodwin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0365","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1073\/pnas.0409481102","article-title":"Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites","volume":"102","author":"Sonoda","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0370","article-title":"Activation of human stearoyl-coenzyme A desaturase 1 contributes to the lipogenic effect of PXR in HepG2 cells","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0375","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1124\/mol.114.097287","article-title":"SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver","volume":"87","author":"Li","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0380","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.febslet.2007.03.047","article-title":"T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR","volume":"581","author":"Mitro","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0385","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","article-title":"Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis","volume":"134","author":"Zhou","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0390","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.phrs.2004.03.005","article-title":"PXR and the regulation of apoA1 and HDL-cholesterol in rodents","volume":"50","author":"Bachmann","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0395","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1161\/01.ATV.0000183674.88817.fb","article-title":"Expression of the pregnane X receptor in mice antagonizes the cholic acid-mediated changes in plasma lipoprotein profile","volume":"25","author":"Masson","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0400","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbalip.2008.12.008","article-title":"PXR agonism decreases plasma HDL levels in ApoE3-leiden.CETP mice","volume":"1791","author":"de Haan","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0405","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0410","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0415","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors","volume":"100","author":"Periard","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0420","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archinternmed.2010.197","article-title":"Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case\u2013control study nested within the French Hospital database on HIV ANRS cohort CO4","volume":"170","author":"Lang","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0425","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.104.3.257","article-title":"Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction","volume":"104","author":"Stein","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0430","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1124\/mol.113.085753","article-title":"Pregnane X receptor mediates dyslipidemia induced by the HIV Protease inhibitor amprenavir in mice","volume":"83","author":"Helsley","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0435","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/QAD.0b013e328339192f","article-title":"Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population","volume":"24","author":"Lang","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0440","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874192401105010049","article-title":"HIV and HAART-associated dyslipidemia","volume":"5","author":"Feeney","year":"2011","journal-title":"Open Cardiovasc. Med. J."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0445","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1210\/me.2007-0133","article-title":"The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors","volume":"21","author":"Ricketts","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0450","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1194\/jlr.M600282-JLR200","article-title":"PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine","volume":"48","author":"Li","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0455","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.107.121913","article-title":"Rifaximin is a gut-specific human pregnane X receptor activator","volume":"322","author":"Ma","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0460","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/me.2014-1355","article-title":"Intestinal pregnane x receptor links xenobiotic exposure and hypercholesterolemia","volume":"29","author":"Sui","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0465","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/toxsci\/kfr178","article-title":"Acetyl tributyl citrate, the most widely used phthalate substitute plasticizer, induces cytochrome p450 3a through steroid and xenobiotic receptor","volume":"123","author":"Takeshita","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0470","doi-asserted-by":"crossref","first-page":"33586","DOI":"10.1074\/jbc.M405817200","article-title":"Niemann-pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis","volume":"279","author":"Davis","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0475","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-pick C1 like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0480","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-physiol-012110-142233","article-title":"Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport","volume":"73","author":"Jia","year":"2011","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0485","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1152\/physrev.00019.2011","article-title":"Role of the gut in lipid homeostasis","volume":"92","author":"Abumrad","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0490","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1056\/NEJMoa1405386","article-title":"Inactivating mutations in NPC1L1 and protection from coronary heart disease","volume":"371","author":"I. Myocardial Infarction Genetics Consortium","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0495","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1086\/592116","article-title":"Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy","volume":"47","author":"Wohl","year":"2008","journal-title":"Clin. Infect. dis."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0500","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1097\/QAD.0b013e32833068e3","article-title":"Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients","volume":"23","author":"Chow","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0505","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/j.gastro.2006.08.012","article-title":"CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine","volume":"131","author":"Nauli","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0510","doi-asserted-by":"crossref","first-page":"19493","DOI":"10.1074\/jbc.M703330200","article-title":"CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine","volume":"282","author":"Nassir","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0515","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cmet.2011.11.011","article-title":"Coordination of triacylglycerol and cholesterol homeostasis by DHR96 and the drosophila LipA homolog magro","volume":"15","author":"Sieber","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0520","doi-asserted-by":"crossref","first-page":"22479","DOI":"10.1016\/S0021-9258(18)54597-X","article-title":"Cloning and expression of cDNA encoding human lysosomal acid lipase\/cholesteryl ester hydrolase. similarities to gastric and lingual lipases","volume":"266","author":"Anderson","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0525","doi-asserted-by":"crossref","first-page":"27766","DOI":"10.1074\/jbc.270.46.27766","article-title":"Characterization of lysosomal acid lipase by site-directed mutagenesis and heterologous expression","volume":"270","author":"Sheriff","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0530","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0016-5085(93)90908-U","article-title":"Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans","volume":"105","author":"Carriere","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0535","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0005-2760(86)90234-1","article-title":"Importance of human gastric lipase for intestinal lipolysis: an in vitro study","volume":"879","author":"Gargouri","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0540","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.4049\/jimmunol.0902151","article-title":"Modulation of T lymphocyte function by the pregnane X receptor","volume":"184","author":"Dubrac","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0545","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bcp.2005.06.018","article-title":"Expression of the drug transporters MDR1\/ABCB1, MRP1\/ABCC1, MRP2\/ABCC2, BCRP\/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver","volume":"70","author":"Albermann","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0550","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/135965350400900510","article-title":"Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA","volume":"9","author":"Owen","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0555","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/dmd.107.017228","article-title":"Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects","volume":"36","author":"Siest","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0560","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/me.2011-1303","article-title":"The steroid and xenobiotic receptor negatively regulates B-1 cell development in the fetal liver","volume":"26","author":"Casey","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0565","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1210\/me.2010-0486","article-title":"B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR","volume":"25","author":"Casey","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0570","doi-asserted-by":"crossref","first-page":"17665","DOI":"10.1016\/S0021-9258(17)46753-6","article-title":"Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36","volume":"268","author":"Abumrad","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0575","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI9259","article-title":"Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice","volume":"105","author":"Febbraio","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0580","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1172\/JCI24061","article-title":"Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice","volume":"115","author":"Moore","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0585","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2006.07.015","article-title":"Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36o\/apoEo mice","volume":"192","author":"Guy","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0590","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2006.06.007","article-title":"A CD36-dependent signaling cascade is necessary for macrophage foam cell formation","volume":"4","author":"Rahaman","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0595","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1194\/jlr.M017376","article-title":"Deficiency of PXR decreases atherosclerosis in apoE-deficient mice","volume":"52","author":"Sui","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0600","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.reprotox.2007.07.005","article-title":"Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure","volume":"24","author":"Saal","year":"2007","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0605","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1210\/er.2008-0021","article-title":"Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption","volume":"30","author":"Vandenberg","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0610","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1289\/ehp.0901716","article-title":"Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A","volume":"118","author":"Vandenberg","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0615","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.300.11.1303","article-title":"Association of urinary bisphenol a concentration with medical disorders and laboratory abnormalities in adults","volume":"300","author":"Lang","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008673","article-title":"Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003\/06","volume":"5","author":"Melzer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0625","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.111.069153","article-title":"Urinary bisphenol a concentration and risk of future coronary artery disease in apparently healthy men and women","volume":"125","author":"Melzer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/5f293018-48a3-40ae-96b7-04438d1d9cb9","article-title":"Urinary bisphenol a concentration and angiography-defined coronary artery stenosis","volume":"7","author":"Melzer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0635","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2011.05.001","article-title":"Circulating levels of bisphenol A and phthalates are related to carotid atherosclerosis in the elderly","volume":"218","author":"Lind","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0640","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1289\/ehp.0901717","article-title":"Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol a","volume":"118","author":"Vandenberg","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0645","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000492","article-title":"Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice","volume":"3","author":"Sui","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0650","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0655","unstructured":"Kathryn J. Moore, I. Tabas, macrophages in the pathogenesis of atherosclerosis, Cell, 145 (2011) 341\u2013355."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0660","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0665","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-kappaB, inflammation, and metabolic disease","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0670","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI26283","article-title":"Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation","volume":"116","author":"Zhou","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0675","doi-asserted-by":"crossref","first-page":"17882","DOI":"10.1074\/jbc.M601302200","article-title":"Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents","volume":"281","author":"Gu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0680","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.08.004","article-title":"Xenobiotic receptor meets NF-kappaB, A collision in the small bowel","volume":"4","author":"Xie","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0685","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmet.2008.08.016","article-title":"Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis","volume":"8","author":"Gareus","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0690","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200318580","article-title":"Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice","volume":"112","author":"Kanters","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0695","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1161\/ATVBAHA.112.254573","article-title":"Myeloid-specific IkappaB kinase beta deficiency decreases atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"32","author":"Park","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0700","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.20131281","article-title":"IKKbeta links vascular inflammation to obesity and atherosclerosis","volume":"211","author":"Sui","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0705","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.HYP.0000253478.51950.27","article-title":"Regulation of vascular tone during pregnancy: a novel role for the pregnane X receptor","volume":"49","author":"Hagedorn","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0710","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/cvr\/cvr330","article-title":"Pregnane X receptor regulates drug metabolism and transport in the vasculature and protects from oxidative stress","volume":"93","author":"Swales","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0715","doi-asserted-by":"crossref","first-page":"13174","DOI":"10.1073\/pnas.1312065110","article-title":"Shear stress activation of nuclear receptor PXR in endothelial detoxification","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0720","doi-asserted-by":"crossref","first-page":"30075","DOI":"10.1074\/jbc.M114.578781","article-title":"Xenobiotic pregnane X receptor (PXR) regulates innate immunity via activation of NLRP3 inflammasome in vascular endothelial cells","volume":"289","author":"Wang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0725","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1038\/ncomms9089","article-title":"Synergistic activation of human pregnane X receptor by binary cocktails of pharmaceutical and environmental compounds","volume":"6","author":"Delfosse","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0730","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","article-title":"Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and toll-like receptor 4","volume":"41","author":"Venkatesh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0735","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/adc.2005.088500","article-title":"Endocrine disrupting chemicals: a new and emerging public health problem?","volume":"91","author":"Acerini","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0740","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00204-014-1348-x","article-title":"Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms","volume":"89","author":"Bitter","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0745","doi-asserted-by":"crossref","DOI":"10.1124\/mol.107.041012","article-title":"Regulatory crosstalk between drug metabolism and lipid homeostasis: Car and Pxr Increase Insig-1 expression","author":"Roth","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0750","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.toxlet.2011.11.003","article-title":"Constitutive androstane receptor transactivates the hepatic expression of mouse Dhcr24 and human DHCR24 encoding a cholesterogenic enzyme 24-dehydrocholesterol reductase","volume":"208","author":"Yoshinari","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0755","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbrc.2005.04.071","article-title":"Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I","volume":"331","author":"Sporstol","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagrm.2016.02.015_bb0760","doi-asserted-by":"crossref","first-page":"14076","DOI":"10.1038\/srep14076","article-title":"Statin-activated nuclear receptor PXR promotes SGK2 dephosphorylation by scaffolding PP2C to induce hepatic gluconeogenesis","volume":"5","author":"Gotoh","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874939916300372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874939916300372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T14:41:17Z","timestamp":1654440077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874939916300372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":152,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1874939916300372"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagrm.2016.02.015","relation":{},"ISSN":["1874-9399"],"issn-type":[{"value":"1874-9399","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel functions of PXR in cardiometabolic disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagrm.2016.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}